The candidate vaccine’s next steps will be going through the FDA’s Biologics License Application process.
|Articles|May 21, 2007
NACDS names Gary Wirth VP of state government affairs
Gary Wirth, R.Ph., has been named NACDS VP of state government affairs.
Advertisement
Gary Wirth, R.Ph., has been named NACDS VP of state government affairs. Most recently, Wirth served as director, professional pharmacy services, for Ahold USA. Currently chairman of the Maryland Association of Chain Drug Stores, Wirth will assume his new role on June 11.
To see more Hot off the Press news articles,
To go to the Drug Topics homepage,
Advertisement
Related to this article
The Milken Institute released survey results alongside new data regarding the need for pharmacists in extending effective GLP-1 care.
Through the ACCESS program, Mark Ey, RPh, notes that pharmacies can now start billing for a variety of services they’ve already been providing.
The medication significantly increased risk of pregnancy loss when compared with macrolide antibiotics, amoxicillin, and topical clindamycin for acne.
In part 3, Rebold explores improving the ART formulary protocol through introducing pharmacist-led transition-of-care services.
Our hosts explore why ketone monitoring matters, what pharmacists should know about Libre Duo, and how patient education can support proactive care management.
Mark Ey, RPh, details the patient-focused factors of the ACCESS to Pharmacy Care Program and the ways in which valued care translates to reimbursement.
A new option for adults who have experienced stroke will now be available to further reduce future risk.
Advertisement
Advertisement
Trending on Drug Topics
1
FDA Adds NAION Eye Risk Warning to All GLP-1 Labels
2
The Pharmacy Model Creating New Billing Pathways, Improved Recognition
3
Doxycycline Use Associated with Higher Risk of Pregnancy Loss
4
Wicked Good Cardiometabolic Chat: Ketone Monitoring in Pharmacy Practice
5